The White House has withdrawn Heidi Overton's nomination to head the FDA just before a Senate committee vote. Overton, who was nominated by President Trump, faced tough questions during her confirmation hearing, particularly regarding her stance on vaccines and healthcare. Senators expressed concerns about her ability to stand up to the president on health-related issues. Kyle Diamantas has been serving as the acting head of the FDA since the previous commissioner resigned.
Key facts
- Heidi Overton's FDA nomination was withdrawn one day before a Senate vote.
- President Trump nominated Overton in August to succeed Marty Makary.
- Overton affirmed the safety of the MMR vaccine during her hearing.
- Kyle Diamantas has been acting head of the FDA since May.
- Erik Baptist called for commitments from the next FDA nominee on abortion drug safety.
A short AI summary in our own words. The reporting belongs to Fox News — Politics; we don't reproduce it.